Cardioversion of chronic atrial fibrillation?towards a more aggressive approach

Lévy, Samuel

doi:10.1053/euhj.1999.1955

Cited by 4 publications

(2 citation statements)

References 3 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Treatment is simple, does not require invasive procedures, and is carried out on an ambulatory basis without major risks. It has been estimated that in patients with AF lasting longer than 48 hours, the probability of pharmacological conversion to SR is around 15% to 30% (12) and that the efficacy of external ECV without concomitant antiarrhythmic therapy is modest (13).…”

Section: Discussionmentioning

confidence: 99%

Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial

Galperin

Elizari²,

Chiale³

et al. 2001

J Cardiovasc Pharmacol Ther

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial

Galperin

Elizari²,

Chiale³

et al. 2001

J Cardiovasc Pharmacol Ther

View full text Add to dashboard Cite

show abstract

“…The efficacy of a direct cardioverter-defibrillator in patients with PAF is on average about 75% and varies between 60% and 90%. The final effect depends on the energy and the type of impulse used [36,37]. AM seems to be the most validated among numerous AADs with documented properties of restoring SR [38,39].…”

Section: Discussionmentioning

confidence: 99%

Wyniki profilaktycznej terapii radiojodem u chorych w stanie eutyreozy z nadczynnością tarczycy w wywiadzie przed podaniem amiodaronu z utrwalonym migotaniem przedsionków — badanie wstępne

Czarnywojtek¹,

Zgorzalewicz-Stachowiak²,

Woliński³

et al. 2014

Endokrynologia Polska

View full text Add to dashboard Cite

Introduction: Radioiodine (RAI) therapy is a standard procedure in the treatment of hyperthyroidism. However, the use of RAI in euthyroid patients requiring chronic administration of amiodarone (AM) where other antiarrhythmic drugs may lack efficacy is still controversial. Objective: The aim of this study was to assess the safety and efficacy of an AM therapy prior to treatment with radioiodine therapy in euthyroid patients with permanent atrial fibrillation (PAF), who had been treated for hyperthyroidism in the past. Material and methods:This was a retrospective observational study. Patients were assessed at baseline and two, six, eight, and 12 months after RAI therapy. 17 euthyroid patients with PAF were qualified to the RAI (female/male 3/14; age range 65 to 87, median 71). The patients required chronic administration of AM as a prophylaxis against sudden death. Results: Each patient received an ablative dose of 800 MBq (22 mCi) of

show abstract